1. Home
  2. CERT vs QDEL Comparison

CERT vs QDEL Comparison

Compare CERT & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Certara Inc.

CERT

Certara Inc.

HOLD

Current Price

$7.75

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Logo QuidelOrtho Corporation

QDEL

QuidelOrtho Corporation

HOLD

Current Price

$17.49

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CERT
QDEL
Founded
2008
1979
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
2020
2022

Fundamental Metrics

Financial Performance
Metric
CERT
QDEL
Price
$7.75
$17.49
Analyst Decision
Buy
Hold
Analyst Count
10
4
Target Price
$11.67
$28.25
AVG Volume (30 Days)
3.7M
1.1M
Earning Date
05-11-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
87.50
45.35
EPS
N/A
N/A
Revenue
$418,838,000.00
$2,730,200,000.00
Revenue This Year
$4.18
$3.51
Revenue Next Year
$5.39
$3.86
P/E Ratio
N/A
N/A
Revenue Growth
8.75
N/A
52 Week Low
$4.45
$9.92
52 Week High
$13.88
$35.58

Technical Indicators

Market Signals
Indicator
CERT
QDEL
Relative Strength Index (RSI) 45.77 N/A
Support Level $6.57 N/A
Resistance Level $7.44 N/A
Average True Range (ATR) 0.37 0.00
MACD -0.03 0.00
Stochastic Oscillator 22.86 0.00

Price Performance

Historical Comparison
CERT
QDEL

About CERT Certara Inc.

Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.

About QDEL QuidelOrtho Corporation

QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.

Share on Social Networks: